0000818479false00008184792024-05-222024-05-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

May 22, 2024
Date of Report (Date of earliest event reported)

DENTSPLY SIRONA Inc.
(Exact name of registrant as specified in its charter)
Delaware
0-16211
39-1434669
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
13320 Ballantyne Corporate Place,
Charlotte
North Carolina
28277-3607
(Address of Principal Executive Offices)
(Zip Code)
(844) 848-0137
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareXRAYThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o





Item 5.07 Submission of Matters to A Vote of Security Holders

The annual meeting of stockholders (the “Annual Meeting”) of DENTSPLY SIRONA Inc. (the “Company”) was held on May 22, 2024. The following matters were voted upon at the Annual Meeting, with the results indicated:

1.Election of ten directors to serve until the next annual meeting of stockholders or until his or her successor is duly elected and qualified.
Director
For
Against
Abstain
Broker Non-Votes
1a.
Simon D. Campion
184,337,365
692,426
38,418
8,688,288
1b.
Willie A. Deese
177,069,194
7,954,618
44,397
8,688,288
1c.
Brian T. Gladden
184,346,064
665,383
56,762
8,688,288
1d.
Betsy D. Holden
180,353,110
4,664,764
50,335
8,688,288
1e.
Clyde R. Hosein
184,349,456
674,826
43,927
8,688,288
1f.
Gregory T. Lucier
178,235,718
6,775,065
57,426
8,688,288
1g
Jonathan J. Mazelsky
183,281,714
1,740,552
45,943
8,688,288
1h.
Leslie F. Varon
180,519,605
4,510,971
37,633
8,688,288
1i.
Janet S. Vergis
182,136,304
2,887,552
44,353
8,688,288
1j.
Dorothea Wenzel
184,389,806
634,265
44,138
8,688,288

2.Ratification of appointment of Deloitte and Touche LLP as the Company’s independent registered public accountants for 2024.
For
Against
Abstain
Broker Non-Votes
192,580,930
1,064,783
110,784

3.Approval, by non-binding advisory vote, of the Company's executive compensation for 2023.
For
Against
Abstain
Broker Non-Votes
178,954,391
6,034,486
79,332
8,688,288
4.Approval of the Company’s 2024 Omnibus Incentive Plan.
For
Against
Abstain
Broker Non-Votes
174,769,033
10,224,723
74,453
8,688,288

5.Approval of the Company’s Amended and Restated Employee Stock Purchase Plan.
For
Against
Abstain
Broker Non-Votes
184,209,731
770,763
87,715
8,688,288




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

            DENTSPLY SIRONA Inc.

By:
/s/ Richard C. Rosenzweig
Richard C. Rosenzweig
Executive Vice President, Corporate Development,
General Counsel and Secretary

Date: May 22, 2024

v3.24.1.1.u2
Cover Page
May 22, 2024
Cover [Abstract]  
Entity Central Index Key 0000818479
Amendment Flag false
Document Type 8-K
Document Period End Date May 22, 2024
Entity Registrant Name DENTSPLY SIRONA Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 0-16211
Entity Tax Identification Number 39-1434669
Entity Address, Address Line One 13320 Ballantyne Corporate Place,
Entity Address, City or Town Charlotte
Entity Address, State or Province NC
Entity Address, Postal Zip Code 28277-3607
City Area Code 844)
Local Phone Number 848-0137
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol XRAY
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

DENTSPLY SIRONA (NASDAQ:XRAY)
過去 株価チャート
から 5 2024 まで 6 2024 DENTSPLY SIRONAのチャートをもっと見るにはこちらをクリック
DENTSPLY SIRONA (NASDAQ:XRAY)
過去 株価チャート
から 6 2023 まで 6 2024 DENTSPLY SIRONAのチャートをもっと見るにはこちらをクリック